Alistair Nichol to Treatment Outcome
This is a "connection" page, showing publications Alistair Nichol has written about Treatment Outcome.
Connection Strength
0.050
-
Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review. Cochrane Database Syst Rev. 2020 12 21; 12:CD013819.
Score: 0.008
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.008
-
Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis. J Neurotrauma. 2019 09 01; 36(17):2541-2548.
Score: 0.007
-
Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis. Ann Surg. 2018 03; 267(3):585-589.
Score: 0.007
-
Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults. N Engl J Med. 2017 11 09; 377(19):1858-1867.
Score: 0.007
-
Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial. J Trauma Acute Care Surg. 2017 09; 83(3):449-456.
Score: 0.007
-
Craniectomy for Traumatic Intracranial Hypertension. N Engl J Med. 2016 12 15; 375(24):2402.
Score: 0.006